Compounds > fluorouracil

fluorouracil and ngr peptide

fluorouracil has been researched along with ngr peptide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jia, Y; Jing, F; Liu, N; Luan, Y; Mou, J; Wang, X; Xu, W; Zhang, J; Zou, M1
Cui, SX; Qu, XJ; Xu, WF; Zhang, HL1

Other Studies

2 other study(ies) available for fluorouracil and ngr peptide

ArticleYear
Design, synthesis, and activity evaluation of a new 5-fluorouracil prodrug containing an Asn-Gly-Arg(NO2)COOCH3 tripeptide.
    Protein and peptide letters, 2012, Volume: 19, Issue:10

    Topics: Animals; Antimetabolites, Antineoplastic; CD13 Antigens; Cell Movement; Cells, Cultured; Collagen; Drug Combinations; Drug Design; Female; Fluorouracil; Human Umbilical Vein Endothelial Cells; Humans; Laminin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neovascularization, Pathologic; Oligopeptides; Prodrugs; Proteoglycans; Sarcoma 180; Xenograft Model Antitumor Assays

2012
13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13).
    European journal of pharmacology, 2014, Jul-05, Volume: 734

    Topics: Animals; Apoptosis; CD13 Antigens; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Mice; Molecular Targeted Therapy; Oligopeptides; Prodrugs; Xenograft Model Antitumor Assays

2014